Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cholecystokinin receptors (CCK receptors) are a family of G-protein coupled receptors (GPCRs) that mediate the physiological effects of the peptide hormones cholecystokinin (CCK) and gastrin. There are two main subtypes: CCK A receptor (CCKAR/CCK1R) and CCK B receptor (CCKBR/CCK2R). They play roles in digestion, behavior, and appetite control.
Agonists bind to the receptor, activating Gq proteins, leading to phospholipase-C stimulation and increased intracellular calcium. Antagonists block the receptor, preventing activation by endogenous ligands.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholecystokinin Receptor (CCK Receptor).